Prot# NU 10B07: Phase II Neoadjuvant Trial with Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Project: Research project

Project Details

StatusFinished
Effective start/end date6/15/11 → 6/15/17

Funding

  • Eisai, Inc. (NU 10B07)